Investigating how Huntingtin protein affects cellular processes in Huntington's disease
Official title: The role of Huntingtin in endolysosomal trafficking and Huntington's disease pathogenesis
Funded at University of Texas Hlth Sci Ctr Houston · NIH-11075519 · Data updated 2026-11-12
This study is looking at how a protein called Huntingtin works with another protein to help keep brain cells healthy, which could help us understand Huntington's disease better and find new ways to treat it.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Sci Ctr Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | September 18, 2024 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $38,124 |
| NIH project number | 1F99NS141400-01 |
| Project ID | NIH-11075519 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Huntington's disease or those at risk due to family history.
✕Less likely to help
Patients with other neurodegenerative diseases unrelated to Huntington's disease may not receive direct benefits from this research.
What this research studies
This research explores the role of the Huntingtin protein in the endolysosomal trafficking process, which is crucial for maintaining healthy neurons. By studying the interactions between Huntingtin and its partner HAP40 in a model organism, the research aims to uncover how these proteins contribute to the development of Huntington's disease. The approach involves genetic and biochemical analyses to understand the underlying mechanisms that lead to neurodegeneration. Patients may benefit from insights that could lead to new therapeutic strategies targeting these cellular pathways.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that slow down or prevent the progression of Huntington's disease.
How similar studies have gone: Previous research has shown promising results in understanding the role of cellular processes in neurodegenerative diseases, suggesting that this approach may yield valuable insights.
Where this research is happening
-
University of Texas Hlth Sci Ctr Houston
Houston, United States Active
Researchers
- Principal investigator: Farmer, Stephen M — University of Texas Hlth Sci Ctr Houston
- Study coordinator: Farmer, Stephen M
Related research
Other NIH-funded projects on the same topics.
-
Understanding CAG repeat instability in Huntington’s disease
A Huntington’s disease study explores why the CAG repeat in the HTT gene becomes unstable and leads to earlier disease, aiming to uncover factors that influence when and how the disease starts.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.